BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin Y, Zhang Y, Chen Y, Liu Z. Promoter methylation and clinical significance of GPX3 in esophageal squamous cell carcinoma. Pathology - Research and Practice 2019;215:152676. [DOI: 10.1016/j.prp.2019.152676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Nirgude S, Choudhary B. Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer. Biochem Pharmacol 2021;184:114365. [PMID: 33310051 DOI: 10.1016/j.bcp.2020.114365] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
2 Wei J, Xie Q, Liu X, Wan C, Wu W, Fang K, Yao Y, Cheng P, Deng D, Liu Z. Identification the prognostic value of glutathione peroxidases expression levels in acute myeloid leukemia. Ann Transl Med 2020;8:678. [PMID: 32617298 DOI: 10.21037/atm-20-3296] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
3 Yuan Y, Du Y, Wang L, Liu X. The value of endothelin receptor type B promoter methylation as a biomarker for the risk assessment and diagnosis of prostate cancer: A meta-analysis. Pathol Res Pract 2020;216:152796. [PMID: 31926772 DOI: 10.1016/j.prp.2019.152796] [Cited by in F6Publishing: 2] [Reference Citation Analysis]